Advancing Anti-Fibrotic Innovation: A Clinical Update on Deupirfenidone & Considerations for Real-World Access
- Overview of the clinical development journey of deupirfenidone, including key learnings from the Phase 2b study and plans for advancing to Phase 3
- Discussion of trial design rationale, patient population, endpoints, and positioning within the current IPF treatment landscape